2011 Annual Meeting

Session: Integrated API and Drug Product Development

Chair

Thakur, R., Novartis Pharma AG

Co-Chair

Mackaplow, M. B., Abbott Laboratories

Presentations

08:30 AM

(32a) Correlating Powder Flowability to Particle Size Distribution Using Chemometric Techniques
Roginski, R. T.

08:50 AM

(32b) Optimization of API Attributes and Flow Properties Via Crystallization and Size Reduction Techniques
Grigorov, P., Lekhal, A., Zarkadas, D.

09:10 AM

(32c) Crystallization and Milling Development Enabling A High Drug Load Formulation
Hoffman, P., Vicenzi, J.

09:30 AM

(32d) Analysis of Bayesian Linearity (BL) to Improve Performance for API to DP Integration
Einstiene, D. A. I. C.

09:50 AM

(32e) API Particle Engineering As a Strategy to Address Sticking/Picking During Drug Product Development
McDermott, T., Sheikh, A., Gandarilla, J.

10:10 AM

(32f) Utilizing Drop-On-Demand Printing In the Manufacture of Transdermal Dosage Forms
Brown, M.

10:30 AM

(32g) API Excipient Co-Crystal Screen to Optimize Robustness of An Oral Solution Drug Product
Luthra, S., Krzyzaniak, J., Murphy, B., Samas, B.